23-valent polysaccharide pneumococcal vaccine

also known as PSV-23 vaccine

Investigated by: Asan Medical Center · Chung-Ang University Hospital · Ewha Womans University · Inje University · Keimyung University Dongsan Medical Center · Konkuk University Hospital
+9 more
· Korea University · Kosin University Gospel Hospital · Kyunghee University Medical Center · Seoul National University Hospital · Severance Hospital · Soonchunhyang University Hospital · The Catholic University of Korea · Wonju Severance Christian Hospital · Wonkwang University

today NCT01505855 · Ph 4

2012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 41 trial
Phase 4	NCT01505855	Dec 2011 → Jun 2013	Crohn disease	Kyunghee University Medical Center	Completed	No outcome recorded
Comparator or background therapy1 trial
Phase 1/2	NCT07418372 Comparator	Mar → Aug 2026 overdue	diphtheria, pertussis, tetanus	Institute of Medical Biology, Chinese Academy of Medical Sciences	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	23-valent polysaccharide pneumococcal vaccine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07418372 ↗ 1 NCT01505855 ↗
Known as	PSV-23 vaccine	“23-valent polysaccharide pneumococcal vaccine (PSV-23 vaccine) 0.5mL single intramuscular injection” NCT01505855 ↗
Modality	Vaccine	“23-valent polysaccharide pneumococcal vaccine” NCT01505855 ↗
Route	Intramuscular	“single intramuscular injection” NCT01505855 ↗